Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing

Sara Ashley O'Brien

👤 Speaker
80 total appearances

Appearances Over Time

Podcast Appearances

WSJ What’s News
Why Everyone Is Talking About Peptides

I think it is a different symptom of the same cause.

WSJ What’s News
Why Everyone Is Talking About Peptides

For a long time, people have been taking photos of celebrities to their plastic surgeons and saying, hey, I want to look like this.

WSJ What’s News
Why Everyone Is Talking About Peptides

And this is another layer of that.

WSJ What’s News
Why Everyone Is Talking About Peptides

We've become increasingly sort of used to sourcing health advice and beauty advice and all that from the Internet, from people that feel like our peers rather than from like the experts themselves.

WSJ What’s News
Why Everyone Is Talking About Peptides

For a long time, the conversation around beauty and looks and appearances and like the drastic measures people will go to has focused on women.

WSJ What’s News
Why Everyone Is Talking About Peptides

But that is spreading and young men are feeling that.

WSJ What’s News
Why Everyone Is Talking About Peptides

And this is not to say that the young men are the primary cohort that is injecting peptides at home.

WSJ What’s News
Why Everyone Is Talking About Peptides

They are a part of it, but so are women.

WSJ What’s News
Why Everyone Is Talking About Peptides

middle-aged women, so are young women, so are postmenopausal women.

WSJ What’s News
Why Everyone Is Talking About Peptides

Everybody is asking this question of like, huh, is there more that I should be doing that I could be doing?

WSJ What’s News
Why Everyone Is Talking About Peptides

And part of it is that people are really focused on longevity now, like how to sort of live the healthiest and best version of their lives for as long as they can.

WSJ What’s News
Why Everyone Is Talking About Peptides

And it's sort of like in these different buckets of aesthetics and longevity and wellness, and you'd be hard-pressed to find a person that wasn't impacted by all that messaging.

WSJ What’s News
Why Everyone Is Talking About Peptides

In late July, the FDA is going to have an advisory panel meet to discuss whether it would allow some of these peptides that were restricted back in 2023 to be compounded again by compounding pharmacies, which would therefore make them much more widely available through doctors, through compounding pharmacies, through telehealth companies and all of that.

WSJ What’s News
Why Everyone Is Talking About Peptides

A lot of people are starting to anticipate what that might mean for the peptide industry.

WSJ What’s News
Why Everyone Is Talking About Peptides

Will we see a lot of telehealth companies get into this?

WSJ What’s News
Why Everyone Is Talking About Peptides

Will we see a lot more doctors feel comfortable prescribing it?

WSJ What’s News
Why Everyone Is Talking About Peptides

Will that take away the gray market research use only peptide marketplace?

WSJ What’s News
Why Everyone Is Talking About Peptides

Even if some of these peptides would become more widely available, does that answer the questions around safety and effectiveness and all that?

WSJ What’s News
Why Everyone Is Talking About Peptides

Whether there will be more data presented to prove that case?

WSJ What’s News
Why Everyone Is Talking About Peptides

Thank you.

← Previous Page 4 of 4 Next →